Class: DPP4 Inhibitor
- Panacea Biotech is having strong presence in Diabetes market through Diacar Alpha Business Team. Panacea Biotech is holding leadership position in Glicazide market with its brand Glizid-M.
- Teneligliptin will further strengthen the position of Panacea in diabetes market segment.
- Teneligliptin works in synergy with the sulphonylureas to manage the patients with uncontrolled on Metformin therapy and / or a sulphonylurea therapy.